A few days ago, we received a document. Opening it, we saw it was MeDomino's Beijing "Innovative" SME certificate.
Previously, we had already obtained dual high-tech certifications: Zhongguancun High-Tech Enterprise and National High-Tech Enterprise. This recognition as a Beijing "Innovative" SME is another official acknowledgement of our work.
For innovative SME certification, companies are evaluated not only on continuous technological innovation but also on business performance. We do not need to be too modest here: compared with 2021, MeDomino's revenue growth rate last year exceeded 300%. Thank you to all pharma and medtech clients for your support. Even amid the broader anti-corruption environment in pharma, receiving official innovation recognition through big data + artificial intelligence technology for the vertical pharma and medtech industry is strong proof that MeDomino's products are legal and compliant.
Coincidentally, MeDomino Content Hub, the leading product that helped MeDomino obtain these certifications, was also recently approved by the China National Intellectual Property Administration as a registered trademark. This means the name "MeDomino Content Hub" is exclusively ours.
Since it has received national recognition, it is worth introducing again in full:
MeDomino Content Hub was created specifically for content management in the pharma and medtech industry. It belongs to the key software field within the "six industrial foundations." It solves long-standing pain points that have troubled pharma and medtech companies, including large content volumes, dispersed storage, messy content formats, difficulty in centralized management, difficulty forming enterprise-level knowledge bases, and difficulty with precise reuse. It fills a gap in the digital marketing field for the pharma and medtech industry.
There is another coincidence. Technology is the foundation of the product, and the underlying technology of MeDomino Content Hub passed the review of the China National Intellectual Property Administration more than a month ago, receiving patent rights and an invention patent certificate. This patented invention is the core capability of MeDomino Content Hub: content tagging. With precise tags, large volumes of dispersed, multi-format content can be centrally managed and efficiently reused.
This is what a continuously innovative company looks like: your digital-intelligence partner, MeDomino.
In the future, MeDomino will continue insisting on technological innovation and improving product capabilities, helping the pharma and medtech industry effectively reduce marketing costs, improve operating efficiency, develop legally and compliantly, and contribute to the smooth advancement of Healthy China 2030.
